The New York Society of Security Analysts Presents Conference on Life Sciences Industry Life sciences company executives to deliver presentations to investment professionals at this half-day conference NEW YORK, N.Y., Oct. 15, 2013 (GLOBE NEWSWIRE) -- via PRWEB - Senior executives from publicly-traded life sciences companies will present and provide an update about their businesses, pipelines, and future plans at the New York Society of Security Analysts' Life Sciences Conference on October 30, 2013. Boris Peaker, PhD, CFA, executive director of biotechnology equity research at Oppenheimer & Co. Inc., will give an overview and speak about key market themes and recent trends for the emerging growth biotechnology segment. Executives will then discuss their companies, which include: DARA BioSciences, Inc. DARA BioSciences Inc. is an oncology supportive care pharmaceutical company dedicated to providing healthcare professionals with a synergistic portfolio of medicines to help cancer patients adhere to their therapy and manage side effects arising from their cancer treatments. GenSpera GenSpera's technology combines a powerful, plant-derived cytotoxin with a tumor-targeted prodrug delivery system. NeoStem NeoStem develops and manufactures cell therapies for proprietary technology platforms and for the cell therapy industry. Provectus Pharmaceuticals, Inc Provectus Pharmaceuticals specializes in developing oncology and dermatology therapies. Its novel oncology drug PV-10 is designed to selectively target and destroy cancer cells without harming surrounding healthy tissue, significantly reducing potential for systemic side effects. The Life Sciences Conference will be held on October 30, 2013 from 8:30 a.m.–12:15 p.m. at 1540 Broadway, Suite 1010, New York, NY 10036. Visit http://www.nyssa.org for a complete agenda. There is no charge for press with credentials. Interested members of the press can email press(at)nyssa(dot)org to request admission to this event. About NYSSA Established in 1937, the New York Society of Security Analysts (NYSSA) is a leading forum for the investment community. NYSSA's mission is to promote best practices and the highest professional and ethical standards in the industry. NYSSA is a nonprofit industry organization that provides education and a venue for policymakers and practitioners to discuss the major issues that drive the finance industry and economy. The Society also strives to assist its members and other financial professionals in their career development. With nearly 10,000 members, NYSSA is the largest of the 135 societies of CFA Institute, which has more than 105,000 members globally. This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/nyssa/lifesciences/prweb11229486.htm CONTACT: NYSSA Shauntay Jones firstname.lastname@example.org +1 (646) 871-3423
The New York Society of Security Analysts Presents Conference on Life Sciences Industry
Press spacebar to pause and continue. Press esc to stop.